iShares Health Innovation Active ETF Rating $24.80 -0.32 (-1.29%) As of 12:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatingsBuy This Stock iShares Health Innovation Active ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.74Holdings in BMED have an aggregate rating of Moderate Buy based on 753 analyst ratings issued in the past year covering 42 companies (68.6% of the portfolio).BMED Aggregate Price Target$24.80High Prediction$24.80Average Prediction$24.80Low Prediction$24.80Holdings in BMED have an aggregate price target of $24.80 and a range of $24.80 to $24.80 covering 42 companies (68.6% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.84%ABTAbbott Laboratories$131.420.0%4.9512 of 5 stars2.76$143.78 9.4%21Upcoming EarningsAnalyst Forecast3.50%BSXBoston Scientific$103.52-0.8%4.6284 of 5 stars3.13$116.09 12.1%243.48%MDTMedtronic$89.28-0.5%4.8506 of 5 stars2.59$98.06 9.8%22Positive NewsAnalyst Forecast3.09%EWEdwards Lifesciences$76.94-1.7%4.3863 of 5 stars2.46$80.70 4.9%26Positive NewsAnalyst Forecast2.63%ABBVAbbVie$186.67-1.7%4.7875 of 5 stars2.81$211.29 13.2%27Trending NewsAnalyst Revision2.56%PODDInsulet$290.14-0.6%4.2475 of 5 stars2.83$321.00 10.6%18Positive NewsAnalyst Revision2.33%GILDGilead Sciences$109.12-2.7%4.9054 of 5 stars2.77$111.38 2.1%26Positive NewsOptions VolumeAnalyst Revision2.18%JNJJohnson & Johnson$155.33-1.0%4.792 of 5 stars2.55$171.00 10.1%20Trending NewsUpcoming Earnings2.01%LHLabcorp$245.66-1.7%4.756 of 5 stars2.57$276.38 12.5%14Dividend Announcement1.95%NTRANatera$150.02-5.2%1.6206 of 5 stars3.00$184.63 23.1%15News CoveragePositive News1.95%ARGXargenex$557.31-0.7%4.4128 of 5 stars3.10$728.06 30.6%21Positive News1.90%EXELExelixis$44.16-3.1%4.7822 of 5 stars2.52$45.28 2.5%21Analyst Forecast1.85%EXASExact Sciences$53.07-2.3%4.7402 of 5 stars2.95$70.50 32.8%221.83%ISRGIntuitive Surgical$512.32-0.8%4.7185 of 5 stars2.70$592.86 15.7%20Positive NewsUpcoming EarningsAnalyst Forecast1.73%DXCMDexCom$84.87-0.5%4.7672 of 5 stars2.95$98.85 16.5%22Positive NewsAnalyst Forecast1.72%BMYBristol Myers Squibb$46.45-1.9%4.9054 of 5 stars2.32$57.69 24.2%22Trending NewsAnalyst Revision1.71%AMGNAmgen$293.11-1.3%4.4253 of 5 stars2.35$307.82 5.0%23Positive NewsAnalyst Revision1.64%NBIXNeurocrine Biosciences$131.45-2.7%4.5303 of 5 stars2.87$163.91 24.7%23Trending NewsAnalyst Revision1.62%ALNYAlnylam Pharmaceuticals$311.21-1.4%4.5211 of 5 stars2.80$345.70 11.1%25Positive News1.62%RGENRepligen$118.66-2.2%4.6574 of 5 stars2.69$170.75 43.9%13News CoveragePositive News1.53%AAgilent Technologies$113.19-5.7%4.783 of 5 stars2.54$139.77 23.5%131.53%ONCBeOne Medicines$267.99+6.3%2.5068 of 5 stars3.00$320.67 19.7%6Analyst DowngradeGap Up1.51%GHGuardant Health$48.02-3.5%4.5915 of 5 stars3.00$53.76 12.0%21News CoveragePositive News1.46%DGXQuest Diagnostics$166.23-1.3%4.9535 of 5 stars2.69$185.73 11.7%16Positive NewsUpcoming Earnings1.26%PFEPfizer$24.60-3.0%4.9647 of 5 stars2.45$28.55 16.1%22Trending News1.21%RYTMRhythm Pharmaceuticals$89.36+0.2%3.1614 of 5 stars3.07$91.00 1.8%15Analyst Revision1.21%HOLXHologic$63.37-1.9%4.7236 of 5 stars2.47$78.75 24.3%17Positive News1.19%INSMInsmed$102.83+0.9%4.0819 of 5 stars3.00$108.07 5.1%17Positive News1.16%TECHBio-Techne$51.50-2.1%4.8866 of 5 stars2.50$70.00 35.9%12News Coverage1.05%QGENQiagen$47.41-1.8%3.6001 of 5 stars2.30$49.40 4.2%101.02%WSTWest Pharmaceutical Services$221.12-1.5%4.7469 of 5 stars2.89$320.00 44.7%90.98%DHRDanaher$193.03-2.4%4.9722 of 5 stars2.85$248.43 28.7%20Positive NewsUpcoming Earnings0.97%MCKMcKesson$711.40-0.6%4.5097 of 5 stars2.86$706.83 -0.6%14Positive NewsAnalyst DowngradeInsider Trade0.94%CORCencora$295.00-0.7%4.5104 of 5 stars2.82$306.33 3.8%11Positive News0.93%WATWaters$289.94-4.7%4.8189 of 5 stars2.56$383.31 32.2%18Trending NewsAnalyst ForecastHigh Trading Volume0.84%TMOThermo Fisher Scientific$418.74-1.6%4.9925 of 5 stars2.80$600.30 43.4%20Positive NewsDividend Announcement0.84%SYKStryker$390.96-0.1%4.4735 of 5 stars2.79$428.55 9.6%19Positive News0.83%BBIOBridgeBio Pharma$46.87-1.7%4.6612 of 5 stars3.00$61.20 30.6%15Analyst ForecastAnalyst Revision0.81%IONSIonis Pharmaceuticals$42.02-1.2%4.5382 of 5 stars2.78$58.25 38.6%180.75%CRLCharles River Laboratories International$154.66-2.1%4.8385 of 5 stars2.25$174.54 12.9%16Positive News0.75%BIOBio-Rad Laboratories$248.29-1.0%4.6875 of 5 stars2.75$324.25 30.6%4News CoveragePositive NewsAnalyst DowngradeAnalyst Revision0.71%PTCTPTC Therapeutics$47.78-3.4%4.5493 of 5 stars2.67$65.00 36.0%15Positive NewsAnalyst Revision This page (NYSEARCA:BMED) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
